Mark For: TYLENOL® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76072484 |
Registration Number | 2660253 |
Mark Literal Elements | TYLENOL |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Affidavit Text | SECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20121113. |
Affidavit Text | 1ST RENEWAL 20121113 |
Current Location | GENERIC WEB UPDATE 2012-11-13 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Daniel Chung |
Law Office Assigned | M60 |
Employee Name | CHICOSKI, JENNIFER D |
1ST RENEWAL 20121113 | Renewal Date |
2000-06-16 | Application Filed |
2000-09-07 | Date of First Use |
2000-09-07 | Date of Use In Commerce |
2001-04-03 | Published |
2001-04-03 | Published for Opposition |
2002-12-10 | Trademark Registered |
2012-11-13 | Location: GENERIC WEB UPDATE |
2012-11-13 | Status: Live/Registered |
2012-11-13 | Status: The registration has been renewed. |
2012-12-10 | Renewal Date |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NEW JERSEY UNITED STATES 089337001 |
Legal Entity Type | Corporation |
Legal Entity State | NEW JERSEY |
Party: | ![]() |
Address | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 089337001 |
Legal Entity Type | |
Legal Entity State | NJ |
![]() | IMAGE/TIFF | 2000-06-16 |
![]() | IMAGE/TIFF | 2000-06-16 |
![]() | 2002-08-19 | |
![]() | 2002-08-19 | |
![]() | 2002-12-10 | |
![]() | 2002-12-10 | |
![]() | 2007-12-27 | |
![]() | 2007-12-27 | |
![]() | 2007-12-27 | |
![]() | 2008-12-17 | |
![]() | 2009-02-09 | |
![]() | 2012-10-16 | |
![]() | 2012-10-16 | |
![]() | 2012-11-13 | |
![]() | APPLICATION/XML | 2021-12-10 |
![]() | 2022-05-04 | |
![]() | 2022-05-04 |
IC 005. US 006 018 044 046 051 052. G & S: pharmaceuticals, namely menstrual pain relief medication. FIRST USE: 20000907. FIRST USE IN COMMERCE: 20000907
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | pharmaceuticals, namely menstrual pain relief medication |
Description | Date | Proceeding Number |
---|---|---|
TEAS SECTION 8 & 9 RECEIVED | 2022-05-04 | |
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-12-10 | |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2013-09-04 | |
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2012-11-13 | 67603 |
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2012-11-13 | 67603 |
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2012-11-13 | |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-11-08 | 67603 |
TEAS SECTION 8 & 9 RECEIVED | 2012-10-16 | |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2009-02-09 | 67603 |
ASSIGNED TO PARALEGAL | 2008-12-30 | 67603 |
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2008-12-17 | |
PAPER RECEIVED | 2008-12-17 | |
CASE FILE IN TICRS | 2008-01-03 | |
REGISTERED-PRINCIPAL REGISTER | 2002-12-10 | |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2002-09-30 | |
EXAMINERS AMENDMENT MAILED | 2002-09-23 | |
PAPER RECEIVED | 2002-08-19 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-08-19 | |
LETTER OF SUSPENSION MAILED | 2002-03-07 | |
ASSIGNED TO EXAMINER | 2002-01-25 | 74290 |
STATEMENT OF USE PROCESSING COMPLETE | 2002-01-24 | |
USE AMENDMENT FILED | 2002-01-03 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2001-07-03 | |
PUBLISHED FOR OPPOSITION | 2001-04-03 | |
NOTICE OF PUBLICATION | 2001-03-21 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2000-12-04 | |
EXAMINER'S AMENDMENT MAILED | 2000-11-16 | |
ASSIGNED TO EXAMINER | 2000-11-14 | 74290 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.